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ABSTRACTSIntroduction: Multiple surgical resections may be necessary in chronic
Crohn's disease management. Laparoscopic techniques offer a minimally
invasive approach. The 5-year experience of a Consultant Colorectal
Surgeon in a District General Hospital is described. Short-term outcomes of
elective laparoscopic procedures are emphasized.
Methods: Patient and operative data were extracted from a prospective
database for the period November 2007 to November 2011.
Results: 14 elective laparoscopic procedures were performed on 13 patients
(7 male, 6 female) with Crohn's disease. Median age was 42.8 years (range
17.3-68.9 years). The procedures comprised: 11 right-hemicolectomies, 1
sigmoid-colectomy and 2 ileostomy reversals. 5 were repeat resections for
recurrent disease at the ileo-colic junction. Prior ileo-colic resection had
occurred in 4 patients, (6 prior resections in 1 patient, 3 in 1 patient and 2 in
2 patients). Open conversion occurred in 1 patient, who had undergone
a prior resection. One anastomotic leak (1/14, 7.1%) occurred, following
primary right-hemicolectomy. Median length of stay in the resection group
was 6.5 days (range 2–11 days). No post-operative deaths occurred.
Conclusion: Laparoscopic techniques may be routinely applied to the
surgical management of Crohn's disease; this includes patients requiring
repeated resections in chronic disease, without signiﬁcant additional
morbidity.
0496: AUDIT OF LYMPH NODE HARVEST DURING BOWEL RESECTION
FOR COLORECTAL CANCER
Kersten Morgan-Bates, James Berwin, Santosh Kumar
Somasundaram, Georgios Akritidis, Olagunju Ogunbiyi. Royal Free
hospital NHS Trust, London, UK
Aims: To perform an audit of lymph node (LN) harvest, an independent
prognostic factor for 5 year survival, during colorectal resections. The
National Bowel Cancer Audit in 2010 identiﬁed that the median number of
LNs excised with the specimen should be15 for colonic cancer and 13 for
rectal cancer.
Methods: Retrospective analysis of prospectively collected data was per-
formed of all eligible patients between January 2010 and August 2011
(20 months).
Results: A total of 177 patients were diagnosed with colorectal cancer
during this study period. 72 patients were excluded for a variety of reasons,
but predominantly for metastatic disease (47). Results from 105 patients
are reported. 93 patients had colon cancer resections. 55 (59.1%) of these
patients had more than 15 LNs excised with the specimen. LNs were
positive in 43 (46.2%). 12 patients underwent surgery for rectal cancer. 9
(75%) of these patients had 13 or more lymph nodes excised with the
specimen. LNs were positive in 4(33.3%).
Conclusions: In a majority, the LN yield following colorectal resection at
our centre was above the National average for rectal and colonic cancers in
this study period, but the surgical technique needs to improve for colonic
resections and a re-audit performed.
0540: LARGE BOWEL OBSTRUCTION CAN BE SAFELY TREATED BY
COLONIC STENT INSERTION - CASE SERIES FROM A UK DISTRICT
GENERAL HOSPITAL
Paul Blake 1, Ray Delicata 2, Nicholas Cross 2, Graham Sturgeon 2, Rachel
Hargest 1. 1University Hospital of Wales, Cardiff, UK; 2Nevill Hall Hospital,
Abergavenny, UK
Aim. The aim of this study is to audit our outcomes and experience of
colonic stent insertion for malignant bowel obstruction.
Methods. Retrospective audit of all stent insertions in a single district
general hospital between August 2003 and December 2009. All patients
had presented with acute bowel obstruction caused by malignant colo-
rectal disease. Details were collected prospectively and contemporaneously
onto a database. Stent insertion was a combined endoscopic and ﬂuoro-
scopic procedure involving a colorectal surgeon and consultant radiologist.
Results. Stenting was attempted on 62 occasions in 54 patients. The
technical success rate was 86% and clinical success rate 84%. The indica-
tions for stenting were relief of acute bowel obstruction, palliation and as
a bridge to surgery. There were complications in fourteen cases (22.5%)
including three perforations and one perioperative mortality. There were
three cases of stent migration, six cases of re-stenosis and two stents
became impacted with stool. There were no incidents of acute or delayed
haemorrhage in any patients.Conclusion. Our experience shows that stenting for obstructing colorectal
cancer is a safe and effective method of alleviating acute and impending
bowel obstruction and can be provided safely and effectively in a district
general hospital.
0560: ANTEGRADE COLONIC ENEMA IN ADULT PATIENTS: A SINGLE
SURGEON SERIES
Mohammed Hamdan, Andrew Gee. Department of Colorectal Surgery, Royal
Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK
Aim: The antegrade colonic enema (ACE) procedure is a minimally
invasive treatment for refractory constipation. 47-83% success rates
have been reported. The aim of this study is to demonstrate the outcome
of patients who underwent the ACE procedure in a district general
hospital.
Methods: Retrospective review of all patients who underwent the ACE
procedure for refractory constipation between February 2002 and June
2011. Demographic, operative and follow up data were recorded.
Results: A total of 12 female patients had the ACE procedure performed by
a single colorectal surgeon. Median age was 43 (24-70) years. Median
postoperative hospital stay was 6 (2-17) days. Median follow up was 36
(14-75) months. Conduit stenosis or leakage developed in 4 and 1 patients
respectively requiring surgical revision.1 patient developed an incisional
herniawith subsequent poor conduit function ultimately managedwith an
end ileostomy. 2 failed to use the conduit and are now on laxatives.
Excluding the latter 3, all patients are managing their constipationwithout
laxatives.
Conclusion: The ACE procedure was successful in 75% of patients who
were, thus, able to avoid more aggressive surgery. Patient education and
compliance are essential to improve success rates.
0566: CHEAPER DOES NOT NECESSARILY MEAN INFERIOR
Stephen Magill, Sylvia Brown, Hoey Koh, Mark Vella, Patrick Finn, Lindsey
Chisholm, Andrew Renwick. Royal Alexandra Hospital, Paisley, UK
Aim: A recent service change at one of our sites (site 2) saw the sole uti-
lisation of endoscopic equipment from a cheaper manufacturer. Endo-
scopists favoured the more expensive equipment and thought that service
quality may be affected. The objective of our study is therefore to evaluate
the effect of change of equipment on service quality.
Methods: Data for 836 colonoscopies performed by three colorectal
surgeons on both sites was prospectively collected.
Results: Overall completion rates were 89.9% at site 1 (n¼490) and 92.2%
at site 2 (n¼346) [p¼0.182]. Completion rates for each consultant also
showed no signiﬁcant differences.
The overall usage of Midazolam between sites were comparable (3.576mg
vs. 3.512mg, p¼0.413), however lower doses were observed for two
consultants at site 2 (3.23mg vs 2.79mg, p¼0.00 and 3.19mg vs 2.95mg,
p¼0.022). The use of analgesics showed no statistical differences between
sites. Comfort score comparison showed no statistical differences overall,
however comfort scoring was signiﬁcantly better at site 2 for two
consultants (p¼0.03 and p¼0.02)
Conclusion: Completion rates, use of sedation and comfort scores are
comparable between the sites despite the difference in equipment.
Thereforewe conclude the quality of service provision is not diminished by
the type of equipment utilised.
0586: IS YOUR BLOOD ORDERING SCHEDULE FOR COLORECTAL
RESECTIONS UP TO DATE AND COMPLIANT WITH NATIONAL
GUIDELINES? AN AUDIT OF CROSS-MATCHED BLOOD UTILISATION IN
ELECTIVE COLORECTAL RESECTIONS (ECR)
Virginie Walker, Jane Hughes, Mandy Chadwick, Naomi
MacKenzie. Wrightington, Wigan & Leigh NHS Foundation Trust, Wigan, UK
Aims: Assess compliancy of our blood ordering schedule against national
guidelines by determining cross-matched blood usage in patients under-
going ECR.
Methods: Retrospective data collection for 12 consecutive months, on ECR
(benign and malignant). Patients requiring preoperative blood transfusion
excluded. Data analysed;operation, pre-operative radiotherapy, preoper-
ative and postoperative haemoglobin, units cross-matched, blood
transfusions.
